AAAAAA
Results: 1-25/35
EFFECT OF YM435, A DOPAMINE DA(1) RECEPTOR AGONIST, IN A CANINE MODELOF ISCHEMIC ACUTE-RENAL-FAILURE
Authors:
YATSU T
ARAI Y
TAKIZAWA K
KASAINAKAGAWA C
TAKANASHI M
UCHIDA W
INAGAKI O
TANAKA A
TAKENAKA T
Citation: T. Yatsu et al., EFFECT OF YM435, A DOPAMINE DA(1) RECEPTOR AGONIST, IN A CANINE MODELOF ISCHEMIC ACUTE-RENAL-FAILURE, General pharmacology, 31(5), 1998, pp. 803-807
Authors:
YATSU T
ARAI Y
SUDOH K
SHIBASAKI M
UCHIDA W
INAGAKI O
TANAKA A
TAKENAKA T
Citation: T. Yatsu et al., EFFECT OF YM435, A NOVEL DOPAMINE DA(1) RECEPTOR AGONIST, IN A CANINEMODEL OF ACUTE CONGESTIVE-HEART-FAILURE, General pharmacology, 30(5), 1998, pp. 733-737
Authors:
TAHARA A
TOMURA Y
WADA K
KUSAYAMA T
TSUKADA J
ISHII N
YATSU T
UCHIDA W
TANAKA A
Citation: A. Tahara et al., BINDING CHARACTERISTICS OF YM087, AN AVP RECEPTOR ANTAGONIST, IN RHESUS-MONKEY LIVER AND KIDNEY MEMBRANES, Peptides, 19(4), 1998, pp. 691-696
Authors:
TAHARA A
TOMURA Y
WADA K
KUSAYAMA T
TSUKADA J
ISHII N
YATSU T
UCHIDA W
TANAKA A
Citation: A. Tahara et al., CHARACTERIZATION OF VASOPRESSIN RECEPTOR IN RAT LUNG, Neuropeptides, 32(3), 1998, pp. 281-286
Authors:
TAHARA A
SAITO M
SUGIMOTO T
TOMURA Y
WADA K
KUSAYAMA T
TSUKADA J
ISHII N
YATSU T
UCHIDA W
TANAKA A
Citation: A. Tahara et al., PHARMACOLOGICAL CHARACTERIZATION OF YMO87, A POTENT, NONPEPTIDE HUMANVASOPRESSIN V-1A AND V-2 RECEPTOR ANTAGONIST, Naunyn-Schmiedeberg's archives of pharmacology, 357(1), 1998, pp. 63-69
Authors:
WANG JF
KIKUCHI K
KOO BH
ISHIKAWA Y
UCHIDA W
ISSHIKI M
Citation: Jf. Wang et al., HWE GROWTH AND EVALUATION OF CDTE EPITAXIAL-FILMS ON GAAS, Journal of crystal growth, 187(3-4), 1998, pp. 373-379
Authors:
TAHARA A
TOMURA Y
WADA K
KUSAYAMA T
TSUKADA J
ISHII N
YATSU T
UCHIDA W
TANAKA A
Citation: A. Tahara et al., EFFECT OF YM087, A POTENT NONPEPTIDE VASOPRESSIN ANTAGONIST, ON VASOPRESSIN-INDUCED PROTEIN-SYNTHESIS IN NEONATAL RAT CARDIOMYOCYTE, Cardiovascular Research, 38(1), 1998, pp. 198-205
Authors:
SHIBASAKI K
UCHIDA W
TAKIZAWA K
MASUDA N
OKAZAKI T
INAGAKI O
ASANO M
TAKENAKA T
Citation: K. Shibasaki et al., CARDIOVASCULAR EFFECTS OF YM430, A 1,4-DIHYDROPYRIDINE DERIVATIVE WITH BETA-ADRENOCEPTOR BLOCKING ACTIVITY, IN DOGS AND RATS, Biological & pharmaceutical bulletin, 20(3), 1997, pp. 230-236
Authors:
SATO K
KAWASAKI T
HISAMICHI N
TANIUCHI Y
HIRAYAMA F
KOSHIO H
UCHIDA W
IIZUMI Y
TAKENAKA T
Citation: K. Sato et al., A SELECTIVE AND POTENT FACTOR XA INHIBITOR, YM-60828, EXERTS ITS ANTITHROMBOTIC EFFECT WITH LITTLE PROLONGATION OF BLEEDING-TIME, Thrombosis and haemostasis, 1997, pp. 1195-1195
Authors:
TANIUCHI Y
SAKAI Y
KAWASAKI T
HISAMICHI N
SATO K
KAYAMA M
HIRAYAMA F
KOSHIO H
UCHIDA W
IIZUMI Y
TAKENAKA T
Citation: Y. Taniuchi et al., ANTICOAGULANT AND PHARMACOKINETIC PROFILES OF YM-60828, AN ORALLY-ACTIVE AND PATENT SYNTHETIC INHIBITOR OF FACTOR XA, Thrombosis and haemostasis, 1997, pp. 1203-1203
Authors:
KAWASAKI T
SATO K
TANIUCHI Y
SAKAI Y
HIRAYAMA F
KAKU S
MATSUMOTO Y
UCHIDA W
IIZUMI Y
TAKENAKA T
Citation: T. Kawasaki et al., COMPARATIVE-STUDIES OF AN ORALLY-ACTIVE FACTOR XA INHIBITOR, YM-60828, WITH VARIOUS ANTITHROMBOTIC AGENTS IN A RAT MODEL OF ARTERIAL THROMBOSIS, Thrombosis and haemostasis, 1997, pp. 2413-2413
Authors:
SHIBASAKI K
ARAI Y
UCHIDA W
OKAZAKI T
ASANO M
TAKENAKA T
Citation: K. Shibasaki et al., ANTIANGINAL EFFECTS OF YM430, A NOVEL CALCIUM ENTRY-BLOCKING AND BETA-ADRENOCEPTOR-BLOCKING AGENT IN SEVERAL EXPERIMENTAL ANGINA MODELS, General pharmacology, 29(4), 1997, pp. 545-550
Authors:
YATSU T
UCHIDA W
INAGAKI O
TANAKA A
TAKENAKA T
Citation: T. Yatsu et al., DOPAMINE DA(1) RECEPTOR AGONIST ACTIVITY OF YM435 IN THE CANINE RENALVASCULATURE, General pharmacology, 29(2), 1997, pp. 229-232
Authors:
TAHARA A
TOMURA Y
WADA K
KUSAYAMA T
TSUKADA J
ISHII N
YATSU T
UCHIDA W
TANAKA A
Citation: A. Tahara et al., EFFECT OF YM087, A POTENT NONPEPTIDE VASOPRESSIN ANTAGONIST, ON VASOPRESSIN-INDUCED HYPERPLASIA AND HYPERTROPHY OF CULTURED VASCULAR SMOOTH-MUSCLE CELLS, Journal of cardiovascular pharmacology, 30(6), 1997, pp. 759-766
HEMODYNAMIC CHARACTERIZATION OF YM435, A NOVEL DOPAMINE DA(1) RECEPTOR AGONIST, IN ANESTHETIZED DOGS
Authors:
YATSU T
TAKIZAWA K
KASAINAKAGAWA C
UCHIDA W
TANAKA A
ASANO M
HONDA K
TAKENAKA T
Citation: T. Yatsu et al., HEMODYNAMIC CHARACTERIZATION OF YM435, A NOVEL DOPAMINE DA(1) RECEPTOR AGONIST, IN ANESTHETIZED DOGS, Journal of cardiovascular pharmacology, 29(3), 1997, pp. 382-388
Authors:
SUDOH K
MASUDA N
UCHIDA W
Citation: K. Sudoh et al., DIFFERENT EFFECT OF ANTICHOLINERGIC AGENTS AND POTASSIUM CHANNEL OPENERS ON URINARY-BLADDER RESPONSE TO PELVIC NERVE-STIMULATION IN ANESTHETIZED DOGS, Journal of autonomic pharmacology, 17(2), 1997, pp. 91-96
Authors:
TAHARA A
TOMURA Y
WADA KI
KUSAYAMA T
TSUKADA J
TAKANASHI M
YATSU T
UCHIDA W
TANAKA A
Citation: A. Tahara et al., PHARMACOLOGICAL PROFILE OF YM087, A NOVEL POTENT NONPEPTIDE VASOPRESSIN V-1A AND V-2 RECEPTOR ANTAGONIST, IN-VITRO AND IN-VIVO, The Journal of pharmacology and experimental therapeutics, 282(1), 1997, pp. 301-308
Authors:
SHIBASAKI K
TAKIZAWA K
UCHIDA W
TAKENAKA T
Citation: K. Shibasaki et al., HYPOTENSIVE EFFECTS OF YM430, A 1,4-DIHYDROPYRIDINE DERIVATIVE, IN SPONTANEOUSLY HYPERTENSIVE RATS AND RENAL HYPERTENSIVE DOGS, Japanese Journal of Pharmacology, 73(2), 1997, pp. 113-124
Authors:
SHIBASAKI M
FUJIMORI A
TAKANASHI M
KUSAYAMA T
TOKIOKA T
SATOH Y
OKAZAKI T
UCHIDA W
INAGAKI O
YANAGISAWA I
Citation: M. Shibasaki et al., PHARMACOLOGICAL PROFILE OF YM358, A NOVEL NONPEPTIDE ANGIOTENSIN AT(1) RECEPTOR ANTAGONIST, European journal of pharmacology, 335(2-3), 1997, pp. 167-173
Authors:
SHIBASAKI M
FUJIMORI A
KUSAYAMA T
TOKIOKA T
SATOH Y
OKAZAKI T
UCHIDA W
INAGAKI O
YANAGISAWA I
Citation: M. Shibasaki et al., ANTIHYPERTENSIVE ACTIVITY OF A NONPEPTIDE ANGIOTENSIN-II RECEPTOR ANTAGONIST, YM358, IN RATS AND DOGS, European journal of pharmacology, 335(2-3), 1997, pp. 175-184
Authors:
YATSU T
ARAI Y
TAKIZAWA K
KASAINAKAGAWA C
TAKANASHI M
UCHIDA W
INAGAKI O
TANAKA A
ASANO M
HONDA K
TAKENAKA T
Citation: T. Yatsu et al., RENAL EFFECT OF YM435, A NEW DOPAMINE D-1 RECEPTOR AGONIST, IN ANESTHETIZED DOGS, European journal of pharmacology, 322(1), 1997, pp. 45-53
Authors:
YATSU T
TOMURA Y
TAHARA A
WADA K
TSUKADA J
UCHIDA W
TANAKA A
TAKENAKA T
Citation: T. Yatsu et al., PHARMACOLOGICAL PROFILE OF YMO87, A NOVEL NONPEPTIDE DUAL VASOPRESSINV-1A AND V-2 RECEPTOR ANTAGONIST, IN DOGS, European journal of pharmacology, 321(2), 1997, pp. 225-230
Authors:
SAKAMOTO K
SUTO S
UCHIDA W
Citation: K. Sakamoto et al., MOLECULAR PRECURSOR OF OXYGEN ON SI(111)7X7 SURFACE, Surface science, 358(1-3), 1996, pp. 514-517
Authors:
TOMURA Y
YATSU T
UCHIDA W
INAGAKI O
TANAKA A
TOMIOKA K
YANAGISAWA I
TOICHI T
Citation: Y. Tomura et al., ACUTE AND CHRONIC ADMINISTRATION OF YM087, A NONPEPTIDE VASOPRESSIN ANTAGONIST, IN RATS WITH HIGH-OUTPUT HEART-FAILURE, Circulation, 94(8), 1996, pp. 1544-1544
Authors:
MATSUMOTO Y
TSUZUKI R
MATSUHISA A
TAKAYAMA K
YODEN T
UCHIDA W
ASANO M
FUJITA S
YANAGISAWA I
FUJIKURA T
Citation: Y. Matsumoto et al., NOVEL POTASSIUM CHANNEL ACTIVATORS - SYNTHESIS AND STRUCTURE-ACTIVITYRELATIONSHIP STUDIES OF 3,4-DIHYDRO-2H-1,4-BENZOXAZINE DERIVATIVES, Chemical and Pharmaceutical Bulletin, 44(1), 1996, pp. 103-114